Patient and ward related risk factors in a multi-ward nosocomial outbreak of COVID-19: Outbreak investigation and matched case-control study. 2023

Jenine Leal, and Heidi M O'Grady, and Logan Armstrong, and Devika Dixit, and Zoha Khawaja, and Kate Snedeker, and Jennifer Ellison, and Joyce Erebor, and Peter Jamieson, and Amanda Weiss, and Daniel Salcedo, and Kimberley Roberts, and Karen Wiens, and Matthew A Croxen, and Byron M Berenger, and Kanti Pabbaraju, and Yi-Chan Lin, and David Evans, and John M Conly
Infection Prevention and Control, Alberta Health Services, Calgary, AB, Canada.

Risk factors for nosocomial COVID-19 outbreaks continue to evolve. The aim of this study was to investigate a multi-ward nosocomial outbreak of COVID-19 between 1st September and 15th November 2020, occurring in a setting without vaccination for any healthcare workers or patients. Outbreak report and retrospective, matched case-control study using incidence density sampling in three cardiac wards in an 1100-bed tertiary teaching hospital in Calgary, Alberta, Canada. Patients were confirmed/probable COVID-19 cases and contemporaneous control patients without COVID-19. COVID-19 outbreak definitions were based on Public Health guidelines. Clinical and environmental specimens were tested by RT-PCR and as applicable quantitative viral cultures and whole genome sequencing were conducted. Controls were inpatients on the cardiac wards during the study period confirmed to be without COVID-19, matched to outbreak cases by time of symptom onset dates, age within ± 15 years and were admitted in hospital for at least 2 days. Demographics, Braden Score, baseline medications, laboratory measures, co-morbidities, and hospitalization characteristics were collected on cases and controls. Univariate and multivariate conditional logistical regression was used to identify independent risk factors for nosocomial COVID-19. The outbreak involved 42 healthcare workers and 39 patients. The strongest independent risk factor for nosocomial COVID-19 (IRR 3.21, 95% CI 1.47-7.02) was exposure in a multi-bedded room. Of 45 strains successfully sequenced, 44 (97.8%) were B.1.128 and differed from the most common circulating community lineages. SARS-CoV-2 positive cultures were detected in 56.7% (34/60) of clinical and environmental specimens. The multidisciplinary outbreak team observed eleven contributing events to transmission during the outbreak. Transmission routes of SARS-CoV-2 in hospital outbreaks are complex; however multi-bedded rooms play a significant role in the transmission of SARS-CoV-2.

UI MeSH Term Description Entries
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D004196 Disease Outbreaks Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS. Outbreaks,Infectious Disease Outbreaks,Disease Outbreak,Disease Outbreak, Infectious,Disease Outbreaks, Infectious,Infectious Disease Outbreak,Outbreak, Disease,Outbreak, Infectious Disease,Outbreaks, Disease,Outbreaks, Infectious Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000416 Alberta A province of western Canada, lying between the provinces of British Columbia and Saskatchewan. Its capital is Edmonton. It was named in honor of Princess Louise Caroline Alberta, the fourth daughter of Queen Victoria. (From Webster's New Geographical Dictionary, 1988, p26 & Room, Brewer's Dictionary of Names, 1992, p12)
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D062606 Tertiary Care Centers A medical facility which provides a high degree of subspecialty expertise for patients from centers where they received SECONDARY CARE. Tertiary Hospital,Tertiary Referral Center,Tertiary Referral Hospital,Care Center, Tertiary,Care Centers, Tertiary,Center, Tertiary Care,Center, Tertiary Referral,Centers, Tertiary Care,Centers, Tertiary Referral,Hospital, Tertiary,Hospital, Tertiary Referral,Hospitals, Tertiary,Hospitals, Tertiary Referral,Referral Center, Tertiary,Referral Centers, Tertiary,Referral Hospital, Tertiary,Referral Hospitals, Tertiary,Tertiary Care Center,Tertiary Hospitals,Tertiary Referral Centers,Tertiary Referral Hospitals

Related Publications

Jenine Leal, and Heidi M O'Grady, and Logan Armstrong, and Devika Dixit, and Zoha Khawaja, and Kate Snedeker, and Jennifer Ellison, and Joyce Erebor, and Peter Jamieson, and Amanda Weiss, and Daniel Salcedo, and Kimberley Roberts, and Karen Wiens, and Matthew A Croxen, and Byron M Berenger, and Kanti Pabbaraju, and Yi-Chan Lin, and David Evans, and John M Conly
January 2022, Antimicrobial stewardship & healthcare epidemiology : ASHE,
Jenine Leal, and Heidi M O'Grady, and Logan Armstrong, and Devika Dixit, and Zoha Khawaja, and Kate Snedeker, and Jennifer Ellison, and Joyce Erebor, and Peter Jamieson, and Amanda Weiss, and Daniel Salcedo, and Kimberley Roberts, and Karen Wiens, and Matthew A Croxen, and Byron M Berenger, and Kanti Pabbaraju, and Yi-Chan Lin, and David Evans, and John M Conly
June 2021, Infection & chemotherapy,
Jenine Leal, and Heidi M O'Grady, and Logan Armstrong, and Devika Dixit, and Zoha Khawaja, and Kate Snedeker, and Jennifer Ellison, and Joyce Erebor, and Peter Jamieson, and Amanda Weiss, and Daniel Salcedo, and Kimberley Roberts, and Karen Wiens, and Matthew A Croxen, and Byron M Berenger, and Kanti Pabbaraju, and Yi-Chan Lin, and David Evans, and John M Conly
March 2023, BMC infectious diseases,
Jenine Leal, and Heidi M O'Grady, and Logan Armstrong, and Devika Dixit, and Zoha Khawaja, and Kate Snedeker, and Jennifer Ellison, and Joyce Erebor, and Peter Jamieson, and Amanda Weiss, and Daniel Salcedo, and Kimberley Roberts, and Karen Wiens, and Matthew A Croxen, and Byron M Berenger, and Kanti Pabbaraju, and Yi-Chan Lin, and David Evans, and John M Conly
October 1997, The Journal of hospital infection,
Jenine Leal, and Heidi M O'Grady, and Logan Armstrong, and Devika Dixit, and Zoha Khawaja, and Kate Snedeker, and Jennifer Ellison, and Joyce Erebor, and Peter Jamieson, and Amanda Weiss, and Daniel Salcedo, and Kimberley Roberts, and Karen Wiens, and Matthew A Croxen, and Byron M Berenger, and Kanti Pabbaraju, and Yi-Chan Lin, and David Evans, and John M Conly
March 2022, European journal of hospital pharmacy : science and practice,
Jenine Leal, and Heidi M O'Grady, and Logan Armstrong, and Devika Dixit, and Zoha Khawaja, and Kate Snedeker, and Jennifer Ellison, and Joyce Erebor, and Peter Jamieson, and Amanda Weiss, and Daniel Salcedo, and Kimberley Roberts, and Karen Wiens, and Matthew A Croxen, and Byron M Berenger, and Kanti Pabbaraju, and Yi-Chan Lin, and David Evans, and John M Conly
November 2023, Cureus,
Jenine Leal, and Heidi M O'Grady, and Logan Armstrong, and Devika Dixit, and Zoha Khawaja, and Kate Snedeker, and Jennifer Ellison, and Joyce Erebor, and Peter Jamieson, and Amanda Weiss, and Daniel Salcedo, and Kimberley Roberts, and Karen Wiens, and Matthew A Croxen, and Byron M Berenger, and Kanti Pabbaraju, and Yi-Chan Lin, and David Evans, and John M Conly
September 2006, American journal of infection control,
Jenine Leal, and Heidi M O'Grady, and Logan Armstrong, and Devika Dixit, and Zoha Khawaja, and Kate Snedeker, and Jennifer Ellison, and Joyce Erebor, and Peter Jamieson, and Amanda Weiss, and Daniel Salcedo, and Kimberley Roberts, and Karen Wiens, and Matthew A Croxen, and Byron M Berenger, and Kanti Pabbaraju, and Yi-Chan Lin, and David Evans, and John M Conly
December 2014, BMC infectious diseases,
Jenine Leal, and Heidi M O'Grady, and Logan Armstrong, and Devika Dixit, and Zoha Khawaja, and Kate Snedeker, and Jennifer Ellison, and Joyce Erebor, and Peter Jamieson, and Amanda Weiss, and Daniel Salcedo, and Kimberley Roberts, and Karen Wiens, and Matthew A Croxen, and Byron M Berenger, and Kanti Pabbaraju, and Yi-Chan Lin, and David Evans, and John M Conly
February 2014, The Journal of hospital infection,
Jenine Leal, and Heidi M O'Grady, and Logan Armstrong, and Devika Dixit, and Zoha Khawaja, and Kate Snedeker, and Jennifer Ellison, and Joyce Erebor, and Peter Jamieson, and Amanda Weiss, and Daniel Salcedo, and Kimberley Roberts, and Karen Wiens, and Matthew A Croxen, and Byron M Berenger, and Kanti Pabbaraju, and Yi-Chan Lin, and David Evans, and John M Conly
December 2022, Revista clinica espanola,
Copied contents to your clipboard!